16 May, EOD - Indian

SENSEX 82330.59 (-0.24)

Nifty 50 25019.8 (-0.17)

Nifty Bank 55354.9 (0.00)

Nifty IT 37972.35 (-0.84)

Nifty Midcap 100 57060.5 (0.94)

Nifty Next 50 67078.95 (1.29)

Nifty Pharma 21633.2 (-0.08)

Nifty Smallcap 100 17560.4 (1.86)

16 May, EOD - Global

NIKKEI 225 37753.72 (0.00)

HANG SENG 23345.05 (-0.46)

S&P 5960.5 (0.26)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoValiant Laboratories Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543998 | NSE Symbol : VALIANTLAB | ISIN : INE0JWS01017 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
31-Jan-2025 07-Feb-2025 Quarterly Results Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter ended December 31 2024. Outcome of the Board Meeting dated February 07, 2025. Financial Results for the quarter ended December 31, 2024. (As per BSE Announcement Dated on 07/02/2025)
07-Nov-2024 12-Nov-2024 Accounts Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2024 and any other business matters if required with the permission of the Chairman. Appointment of Mr. Ashok Chheda as a Non- Executive Independent Director of the Company. (As Per BSE Announcement Dated on: 12/11/2024)
06-Aug-2024 12-Aug-2024 Quarterly Results Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Standalone and Consolidated Audited Financial Results for the quarter ended June 30 2024 Outcome of the Board Meeting (As Per Bse Announcement Dated on 12.08.2024)
07-May-2024 14-May-2024 Accounts Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 inter alia to consider and approve Standalone and Consolidated audited Financial Results for the quarter and year ended March 31 2024 and other business matters if required with the permission of the Chairman. Outcome of the Board Meeting Appointment of Mr. Mulesh Manilal Savla as Non- Executive Independent Director of the Company. (As Per BSE Announcement dated on 14.05.2024)
01-Feb-2024 09-Feb-2024 Quarterly Results Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Audited Financial Results for the Quarter ended December 31 2023. Outcome of the Board Meeting (As Per BSE Announcement dated on 09.02.2024)
30-Oct-2023 06-Nov-2023 Quarterly Results Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Audited Financial Results for the Quarter and Half Year ended September 30 2023. Outcome of Board Meeting Audited Financial Results for Quarter and Half year ended September 30, 2023. (As Per BSE Announcement dated on 06.11.2023)

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +